GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » EV-to-EBITDA

Medistim ASA (OSL:MEDI) EV-to-EBITDA : 19.95 (As of May. 19, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medistim ASA's enterprise value is kr3,728.7 Mil. Medistim ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was kr186.9 Mil. Therefore, Medistim ASA's EV-to-EBITDA for today is 19.95.

The historical rank and industry rank for Medistim ASA's EV-to-EBITDA or its related term are showing as below:

OSL:MEDI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.14   Med: 20.51   Max: 53.42
Current: 19.95

During the past 13 years, the highest EV-to-EBITDA of Medistim ASA was 53.42. The lowest was 10.14. And the median was 20.51.

OSL:MEDI's EV-to-EBITDA is ranked worse than
61.94% of 494 companies
in the Medical Devices & Instruments industry
Industry Median: 15.315 vs OSL:MEDI: 19.95

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-19), Medistim ASA's stock price is kr213.00. Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr6.710. Therefore, Medistim ASA's PE Ratio (TTM) for today is 31.74.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Medistim ASA EV-to-EBITDA Historical Data

The historical data trend for Medistim ASA's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA EV-to-EBITDA Chart

Medistim ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.39 47.93 24.13 24.40 16.72

Medistim ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.89 18.66 19.80 16.72 16.17

Competitive Comparison of Medistim ASA's EV-to-EBITDA

For the Medical Devices subindustry, Medistim ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medistim ASA's EV-to-EBITDA falls into.


;
;

Medistim ASA EV-to-EBITDA Calculation

Medistim ASA's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3728.743/186.899
=19.95

Medistim ASA's current Enterprise Value is kr3,728.7 Mil.
Medistim ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr186.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSL:MEDI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medistim ASA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=213.00/6.710
=31.74

Medistim ASA's share price for today is kr213.00.
Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6.710.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Medistim ASA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medistim ASA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines